Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer is a research paper published in Clinical Lung Cancer (2022). On theSindex it has a DataRank of 0.662. It has been cited 19 times, with 16 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0.213
From 10 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 16 citers.
National Institutes of Health
Grant: U10CA180820
National Institutes of Health
Grant: U10CA180821
National Institutes of Health
Grant: U10CA180868
National Institutes of Health
Grant: U10CA180882
National Institutes of Health
Grant: U10CA180888
National Institutes of Health
Grant: UG1CA232760
National Institutes of Health
Grant: UG1CA233180
National Institutes of Health
Grant: UG1CA233191
National Institutes of Health
Grant: UG1CA233253
National Institutes of Health
Grant: UG1CA233277
National Institutes of Health
Grant: 3U10CA180888-03S1
SWOG Network Group Operations Center of the NCTN
National Institutes of Health
Grant: 5UG1CA233180-02
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
National Institutes of Health
Grant: 3UG1CA233191-06S1
Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
National Institutes of Health
Grant: 1UG1CA233253-01
NCI National Clinical Trials Network (UG1)
National Institutes of Health
Grant: 5U10CA180868-09
NRG Oncology Network Group Operations Center
National Institutes of Health
Grant: 3UG1CA232760-06S1
NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1 (funded extension)
National Institutes of Health
Grant: 5U10CA180882-02
Statistics and Data Center for the Alliance for Clinical Trials in Oncology
National Institutes of Health
Grant: 3U10CA180821-02S2
Alliance for Clinical Trials in Oncology Operations Center
National Institutes of Health
Grant: 3UG1CA233277-05S1
National Clinical Trials Network Research at the University of Wisconsin
National Institutes of Health
Grant: 3U10CA180820-02S3
ECOG-ACRIN Operations Center
National Cancer Institute
Foundation for the National Institutes of Health
FWCI
1.58
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals